Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

TNDM enters a multi-year research collaboration with the UVA Center for Diabetes Technology for the development of AID systems.

New research about to get underway at the University of Virginia could help make life easier for people with Type One Diabetes- by possibly developing a fully automated insulin pump.

Tandem Diabetes (TNDM) announced it has signed a multi-year collaboration agreement with the University of Virginia Center for Diabetes ...

Beta Bionics is commercializing innovative insulin delivery technologies, but faces challenges in achieving profitability.

Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering.  Read more here.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it signed a multi-year R&D collaboration agreement with the ...

Diabetes drugs now represent over 75% of total sales in the metabolic disorders market, up from below 40% ten years ago. The ...

A new study published in the NEJM Evidence journal showed that automated insulin delivery reduced hypoglycemia in older ...

UVA Center for Diabetes has signed an agreement to advance research on fully automated insulin delivery systems.